We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Becket Invest Plc | LSE:TAB | London | Ordinary Share | GB00BMWKKL25 | ORD GBP0.01 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.20 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Blank Checks | 0 | -2.27M | -2.7622 | 0.00 | 9.84k |
Hot Features
Premium
RNS No 2054m
THERAPEUTIC ANTIBODIES INC
31st December 1997
THERAPEUTIC ANTIBODIES INC ("the Company")
DEALINGS BY DIRECTORS AND CONNECTED PERSONS
The Company was informed on December 31, 1997 that on that day Mr.Martin Brown
transferred, with no further beneficial interest, 36,190 shares of Common
Stock of $0.01 each to various members of his family and certain other
unconnected persons reducing his beneficial holding to 2,631,633 shares of
Common Stock, representing 11.3% of the issued share capital of the Company.
END
RDSOCDCDKDDDFBN
1 Year Becket Invest Chart |
1 Month Becket Invest Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
